Metformin mediates dual blocking of STAT3-PDL-1 and c-Myc-PDL1 pathways in tumor through upregulation of FOXO3, and therefore, it enhances CD8+ TILs activation [35]. The gene discussed is CD8A; the disease is neoplasm.